Lauren Riker's most recent trade in Pacira BioSciences Inc was a trade of 6,115 Common Stock done at an average price of $23.5 . Disclosure was reported to the exchange on June 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 23.50 per share. | 11 Jun 2026 | 6,115 | 62,284 (0%) | 0% | 23.5 | 143,703 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.32 per share. | 03 Jun 2026 | 3,187 | 68,399 (0%) | 0% | 22.3 | 71,134 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 19,273 | 71,586 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 20.81 per share. | 30 Jan 2026 | 4,000 | 52,313 (0%) | 0% | 20.8 | 83,240 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.54 per share. | 30 Jan 2026 | 2,751 | 56,313 (0%) | 0% | 20.5 | 56,506 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 24.24 per share. | 02 Jan 2026 | 1,416 | 59,064 (0%) | 0% | 24.2 | 34,324 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.46 per share. | 02 Jan 2026 | 159 | 60,480 (0%) | 0% | 24.5 | 3,889 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 26.21 per share. | 03 Jun 2025 | 5,578 | 59,564 (0%) | 0% | 26.2 | 146,208 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.40 per share. | 03 Jun 2025 | 3,374 | 65,142 (0%) | 0% | 26.4 | 89,074 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 30,600 | 68,516 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.33 per share. | 02 Jan 2025 | 159 | 37,916 (0%) | 0% | 18.3 | 2,914 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 12 Jun 2024 | 21,360 | 42,045 (0%) | 0% | 0 | Common Stock | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 12 Jun 2024 | 3,970 | 38,075 (0%) | 0% | 28.7 | 114,018 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 03 Jun 2024 | 1,843 | 20,685 (0%) | 0% | 30.9 | 56,930 | Common Stock | |
| Pacira BioSciences Inc | Riker Lauren | Senior Vice President, Finance | 02 Jan 2024 | 159 | 22,528 (0%) | 0% | 32 | 5,088 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 14 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 14 Jun 2023 | 10,000 | 29,053 (0%) | 0% | 0 | Common Stock | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 14 Jun 2023 | 5,773 | 22,694 (0%) | 0% | 38.5 | 222,376 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 14 Jun 2023 | 586 | 28,467 (0%) | 0% | 37.5 | 21,957 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 14 Jun 2023 | 7 | 22,687 (0%) | 0% | 39 | 273 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 06 Jun 2023 | 616 | 19,053 (0%) | 0% | 37.9 | 23,325 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 06 Jun 2023 | 591 | 19,669 (0%) | 0% | 39.0 | 23,044 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 06 Jun 2022 | 14,600 | 14,600 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 06 Jun 2022 | 5,850 | 19,852 (0%) | 0% | 0 | Common Stock | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 06 Jun 2022 | 1,150 | 14,002 (0%) | 0% | 61.4 | 70,580 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 10 Mar 2022 | 9,300 | 24,452 (0%) | 0% | 10.8 | 100,533 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 10 Mar 2022 | 9,300 | 0 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 10 Mar 2022 | 8,400 | 16,052 (0%) | 0% | 71.1 | 597,576 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 10 Mar 2022 | 900 | 15,152 (0%) | 0% | 72.0 | 64,755 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 18 Jan 2022 | 2,500 | 17,652 (0%) | 0% | 10.8 | 27,025 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 18 Jan 2022 | 2,500 | 9,300 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 18 Jan 2022 | 2,500 | 15,152 (0%) | 0% | 65.0 | 162,430 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 04 Jan 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 04 Jan 2022 | 2,000 | 15,152 (0%) | 0% | 0 | Common Stock |